CTI Recognized for Outstanding Patient Recruitment and Retention at 2024 Fierce Biotech CRO Awards
CTI Clinical Trial & Consulting Services (CTI), a leading global, privately held full-spectrum research service provider, has been awarded the Outstanding Patient Recruitment and Retention honor at the inaugural Fierce Biotech CRO awards. This recognition highlights CTI’s exemplary collaboration with Bexion Pharmaceuticals on groundbreaking clinical trials.
The Fierce Biotech CRO Awards celebrate exceptional achievements in the Contract Research Organization (CRO) sector, recognizing innovation, leadership, and outstanding contributions to advancing clinical research and improving patient outcomes. These awards spotlight organizations that drive life sciences forward through excellence in drug development, clinical trials, and research activities.
"This award is a proud moment for CTI and a testament to our strong partnership with Bexion Pharmaceuticals,” said Adam Roth, Vice President of Research Site Services at CTI’s Clinical Research Center. “Our approach to patient recruitment and retention emphasizes respect, care, and innovation, ensuring every participant’s experience is prioritized. This recognition underscores our dedication to advancing therapies that transform lives worldwide.”
CTI’s winning collaboration with Bexion Pharmaceuticals showcases its ability to navigate the complex challenges of clinical trials, employing patient-centric strategies that foster trust and engagement. This achievement further solidifies CTI’s role as a trusted partner in delivering innovative solutions for global clinical development.
The Fierce Biotech CRO awards were established to honor the critical contributions of CROs in advancing life sciences research and enhancing healthcare outcomes. By promoting best practices and celebrating innovation, these awards underscore the pivotal role CROs play in shaping the future of medicine.
For more information about the Fierce Biotech CRO awards, visit: fierceclinicalsummit.com. For more information about CTI and its industry-leading services, visit: ctifacts.com.
